Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiao Ding

Showing results (511-520 of 540) with videos related to

Pageof 54
Sort By:
RSC Medicinal Chemistry|December 15, 2025
Discovery and optimization of pyrrolopyrimidines as highly potent, selective and brain-penetrant LRRK2 inhibitorsJeffrey M Axten, Xiao Ding, Luigi Piero Stasi, et al.
Science (New York, N.Y.)|December 17, 2011
Equilibrative nucleoside transporter 3 deficiency perturbs lysosome function and macrophage homeostasisChia-Lin Hsu, Weiyu Lin, Dhaya Seshasayee, et al.
Journal of Medicinal Chemistry|July 3, 2018
Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant VariantJian Zhang, Vasanthanathan Poongavanam, Dongwei Kang, et al.
Journal of Medicinal Chemistry|March 12, 2013
Pyrimidoaminotropanes as potent, selective, and efficacious small molecule kinase inhibitors of the mammalian target of rapamycin (mTOR)Anthony A Estrada, Daniel G Shore, Elizabeth Blackwood, et al.
Cancer Research|July 14, 2026
ALKBH5 in Cancer-Associated Fibroblasts Governs an Epitranscriptomic Axis that Drives Pancreatic Cancer MetastasisXianglin Yin, Xiao-Ding Liu, Lulu Cheng, et al.
Bone Research|July 25, 2022
Dynamic changes in O-GlcNAcylation regulate osteoclast differentiation and bone loss via nucleoporin 153Yi-Nan Li, Chih-Wei Chen, Thuong Trinh-Minh, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Mutations, Recombination and Insertion in the Evolution of 2019-nCoVAiping Wu, Peihua Niu, Lulan Wang, et al.
Journal of Medicinal Chemistry|December 4, 2012
Potent, selective, and orally bioavailable inhibitors of the mammalian target of rapamycin kinase domain exhibiting single agent antiproliferative activityMichael F T Koehler, Philippe Bergeron, Elizabeth Blackwood, et al.
Frontiers in Immunology|March 11, 2022
An Fc-Competent Anti-Human TIGIT Blocking Antibody Ociperlimab (BGB-A1217) Elicits Strong Immune Responses and Potent Anti-Tumor Efficacy in Pre-Clinical ModelsXin Chen, Liu Xue, Xiao Ding, et al.
The Journal of Biological Chemistry|June 28, 2005
Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategyXiu-Xia Qu, Pei Hao, Xi-Jun Song, et al.
Pageof 54

Showing results (511-520 of 540) with videos related to

Sort By:
Pageof 54
RSC Medicinal Chemistry|December 15, 2025
Discovery and optimization of pyrrolopyrimidines as highly potent, selective and brain-penetrant LRRK2 inhibitorsJeffrey M Axten, Xiao Ding, Luigi Piero Stasi, et al.
Science (New York, N.Y.)|December 17, 2011
Equilibrative nucleoside transporter 3 deficiency perturbs lysosome function and macrophage homeostasisChia-Lin Hsu, Weiyu Lin, Dhaya Seshasayee, et al.
Journal of Medicinal Chemistry|July 3, 2018
Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant VariantJian Zhang, Vasanthanathan Poongavanam, Dongwei Kang, et al.
Journal of Medicinal Chemistry|March 12, 2013
Pyrimidoaminotropanes as potent, selective, and efficacious small molecule kinase inhibitors of the mammalian target of rapamycin (mTOR)Anthony A Estrada, Daniel G Shore, Elizabeth Blackwood, et al.
Cancer Research|July 14, 2026
ALKBH5 in Cancer-Associated Fibroblasts Governs an Epitranscriptomic Axis that Drives Pancreatic Cancer MetastasisXianglin Yin, Xiao-Ding Liu, Lulu Cheng, et al.
Bone Research|July 25, 2022
Dynamic changes in O-GlcNAcylation regulate osteoclast differentiation and bone loss via nucleoporin 153Yi-Nan Li, Chih-Wei Chen, Thuong Trinh-Minh, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Mutations, Recombination and Insertion in the Evolution of 2019-nCoVAiping Wu, Peihua Niu, Lulan Wang, et al.
Journal of Medicinal Chemistry|December 4, 2012
Potent, selective, and orally bioavailable inhibitors of the mammalian target of rapamycin kinase domain exhibiting single agent antiproliferative activityMichael F T Koehler, Philippe Bergeron, Elizabeth Blackwood, et al.
Frontiers in Immunology|March 11, 2022
An Fc-Competent Anti-Human TIGIT Blocking Antibody Ociperlimab (BGB-A1217) Elicits Strong Immune Responses and Potent Anti-Tumor Efficacy in Pre-Clinical ModelsXin Chen, Liu Xue, Xiao Ding, et al.
The Journal of Biological Chemistry|June 28, 2005
Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategyXiu-Xia Qu, Pei Hao, Xi-Jun Song, et al.
Pageof 54